$1.06
+0.08 (+7.92%)
Open$1.03
Previous Close$0.98
Day High$1.11
Day Low$0.98
52W High$1.57
52W Low$0.38
Volume—
Avg Volume269.0K
Market Cap56.57M
P/E Ratio—
EPS$-0.30
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+2,365.1% upside
Current
$1.06
$1.06
Target
$26.13
$26.13
$16.33
$26.13 avg
$37.99
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 36.3K | 144.7K | 15.27M |
| Net Income | -17,484,991 | -62,695,186 | 4.70M |
| Profit Margin | -51,035.7% | -48,483.9% | 30.8% |
| EBITDA | -16,498,898 | -62,446,028 | 6.30M |
| Free Cash Flow | — | — | 4.04M |
| Rev Growth | -74.9% | -74.9% | -3.4% |
| Debt/Equity | — | — | 0.36 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |